The Effect of Kinisoquin on Thromboembolic Events in Patients With Metastatic Pancreatic Cancer

PHASE3RecruitingINTERVENTIONAL

Enrollment

480

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2029

Conditions

Venous ThromboembolismMetastatic Pancreatic Cancer

Interventions

DRUG

Kinisoquin

Kinisoquin capsules formulated with vitamin C and vitamin B3

DRUG

Placebo

Trial Locations (1)

RECRUITING

Clavis Medical, LLC, Miami Lakes

All Listed Sponsors

lead

Quercis Pharma AG

INDUSTRY